Cargando…
Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach
Epigallocatechin gallate (EGCG), the main ingredient in green tea, holds promise as a potential treatment for pulmonary arterial hypertension (PAH). However, EGCG has many drawbacks, including stability issues, low bioavailability, and a short half-life. Therefore, the purpose of this research was t...
Autores principales: | Haddad, Fatma, Mohammed, Nura, Gopalan, R. C., Ayoub, Yousef Al, Nasim, Md Talat, Assi, K. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965461/ https://www.ncbi.nlm.nih.gov/pubmed/36839861 http://dx.doi.org/10.3390/pharmaceutics15020539 |
Ejemplares similares
-
Nano-liposomal dry powder inhaler of tacrolimus: Preparation, characterization, and pulmonary pharmacokinetics
por: Chougule, Mahavir, et al.
Publicado: (2007) -
Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG—Study on Stability and Anticancer Potential
por: Piwowarczyk, Ludwika, et al.
Publicado: (2022) -
Conjugation Of EGCG And Chitosan NPs As A Novel Nano-Drug Delivery System
por: Safer, Abdel-Majeed, et al.
Publicado: (2019) -
Laryngitis after inhalation of liposomal amikacin
por: Morita, Atsuho, et al.
Publicado: (2022) -
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
por: Bassetti, Matteo, et al.
Publicado: (2020)